- Home
- TURN vs COCH Comparison
TURN vs COCH Comparison
Compare TURN & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TURN
- COCH
- Stock Information
- Founded
- TURN 1981
- COCH 1995
- Country
- TURN United States
- COCH United States
- Employees
- TURN N/A
- COCH N/A
- Industry
- TURN Finance/Investors Services
- COCH Blank Checks
- Sector
- TURN Finance
- COCH Finance
- Exchange
- TURN Nasdaq
- COCH Nasdaq
- Market Cap
- TURN 49.6M
- COCH 25.2M
- IPO Year
- TURN N/A
- COCH N/A
- Fundamental
- Price
- TURN $7.80
- COCH $1.37
- Analyst Decision
- TURN
- COCH Strong Buy
- Analyst Count
- TURN 0
- COCH 2
- Target Price
- TURN N/A
- COCH $9.25
- AVG Volume (30 Days)
- TURN 33.2K
- COCH 128.0K
- Earning Date
- TURN 02-26-2018
- COCH 11-13-2025
- Dividend Yield
- TURN N/A
- COCH N/A
- EPS Growth
- TURN N/A
- COCH N/A
- EPS
- TURN 0.29
- COCH N/A
- Revenue
- TURN $488,011.00
- COCH $222,000.00
- Revenue This Year
- TURN N/A
- COCH $4.27
- Revenue Next Year
- TURN N/A
- COCH $23.37
- P/E Ratio
- TURN $17.34
- COCH N/A
- Revenue Growth
- TURN 277.43
- COCH N/A
- 52 Week Low
- TURN $3.12
- COCH $1.06
- 52 Week High
- TURN $5.01
- COCH $3.99
- Technical
- Relative Strength Index (RSI)
- TURN 86.44
- COCH 54.18
- Support Level
- TURN $7.73
- COCH $1.23
- Resistance Level
- TURN $8.74
- COCH $1.39
- Average True Range (ATR)
- TURN 0.25
- COCH 0.08
- MACD
- TURN 0.36
- COCH 0.02
- Stochastic Oscillator
- TURN 77.78
- COCH 91.30
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.